Home>Topics>Companies>Sigma-Aldrich

Sigma-Aldrich SIAL

  1. All
  2. Commentary
  3. Headlines
    1. Merck KGaA places $4 bln bond to fund Sigma-Aldrich deal

      Headlines

      Tue, 17 Mar 2015

      FRANKFURT, March 17 (Reuters) - Germany's Merck KGaA on Tuesday placed a $4 billion bond with institutional investors to help fund its $17 billion acquisition of U.S. lab supplies company Sigma - Aldrich .

    2. Merck KGaA Posts In-Line Fourth Quarter, Benefits From Foreign Exchange

      Commentary

      Tue, 3 Mar 2015

      a decade of consistent price increases, we estimate that Rebif's margin is well above the company average. The Sigma - Aldrich deal is still expected to close in mid-2015. The transaction will help reduce Merck's reliance on its underperforming

    3. Sigma-Aldrich Overcomes Previous Headwinds With Strong 4Q Performance

      Commentary

      Thu, 12 Feb 2015

      Sigma - Aldrich 's fourth-quarter results slightly exceeded our expectations thanks to particularly strong growth in the commercial business

    4. Sigma-Aldrich Meets Expectations Prior to Merck Deal

      Commentary

      Thu, 23 Oct 2014

      Sigma - Aldrich ’s third-quarter results mostly matched our expectations, with strength in the applied segment offsetting ongoing sluggish performance

    5. UPDATE 1- Sigma-Aldrich's $17 bln buyout seen as boost for lab supplier VWR

      Headlines

      Tue, 23 Sep 2014

      Sept 23 (Reuters) - The large premium Germany's Merck KGaA agreed to pay in a $17 billion acquisition of Sigma - Aldrich Corp shines a spotlight on, and potentially raises the value of, a company Merck...

    6. Merck Drives Further Diversification Through Planned Acquisition of Sigma-Aldrich

      Commentary

      Mon, 22 Sep 2014

      Merck KGaA intends to expand the company’s life sciences operations with a $17 billion all-cash acquisition of Sigma - Aldrich , which comes to approximately $140 per share. The deal will continue to diversify Merck’s operations, while also

    7. Sigma-Aldrich Foresees Improvements as Growth Remains Sluggish

      Commentary

      Thu, 24 Jul 2014

      Ongoing research budget spending pressure and the delay of large contract manufacturing orders sustained weak growth for Sigma - Aldrich during the second quarter. Gross margin expansion and tight operating cost controls kept earnings growth on track

    8. Sigma’s Margin Expansion Efforts Help Offset Growth Challenges

      Commentary

      Thu, 24 Apr 2014

      We don’t plan to change our $87 fair value estimate or narrow moat rating for Sigma - Aldrich after the company’s first-quarter results mostly met our expectations. Organic revenue growth of 3% fell slightly below our

    9. Sigma Should Witness Steady Growth in 2014 Despite Persistent Challenges

      Commentary

      Fri, 7 Feb 2014

      We don't expect to make any changes to our fair value estimate for Sigma - Aldrich as the company’s performance continues to mostly track our expectations. Consistent with our forecast, organic revenue increased

    10. Life Sciences Help Boost Sigma-Aldrich ’s Third-Quarter Performance

      Commentary

      Tue, 22 Oct 2013

      Sigma - Aldrich reported third-quarter results in line with our expectations. Management increased the lower end of its EPS outlook on a favorable

    « Prev12345Next »
    Content Partners